Beijing Scitop Bio-tech Co., Ltd.

SZSE:300858.SZ

19.72 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q22018 Q1
Revenue 77.32958.43880.55177.01567.78472.148105.067107.24370.78886.06896.322100.98986.5980.71795.287103.72280.78759.36389.882.57283.27752.4574.41674.416
Cost of Revenue 37.11426.95339.03932.11633.01834.24952.37447.81935.32741.7754.01645.06240.80641.28356.42248.78638.4731.59745.735.87842.54226.51538.31338.313
Gross Profit 40.21531.48541.51144.89934.76637.89852.69359.42435.46144.29842.30655.92645.78439.43438.86554.93742.31727.76644.146.69440.73525.93536.10336.103
Gross Profit Ratio 0.520.5390.5150.5830.5130.5250.5020.5540.5010.5150.4390.5540.5290.4890.4080.530.5240.4680.4910.5650.4890.4940.4850.485
Reseach & Development Expenses 7.3278.0098.6789.5728.6286.4945.1925.8943.3677.6365.7427.7137.3336.3624.7075.0834.3693.4146.0714.0872.3212.2743.0143.014
General & Administrative Expenses -1.8656.321-12.35611.255-2.7876.401-10.40614.952-4.4057.489-9.81621.498-3.2197.317-8.6376.743-2.113.951-8.3974.9323.5394.5764.7974.797
Selling & Marketing Expenses 10.4635.46210.8566.6048.7517.7268.4646.4686.7955.5055.8217.2517.114.8244.8526.3444.1222.7512.5275.8655.0243.0283.1243.124
SG&A 14.3411.99917.17817.865.96414.127-1.94221.422.3912.994-3.99428.7493.89112.142-3.78413.0872.0126.702-5.8710.7978.5637.6048.1688.168
Other Expenses -0.060.003-0.1670.003-0.3990.002-0.8750.0160.003-1.065-0.234-0.1-0.097-0.1-1.3840.088-0.983-2.257-0.1360.0020.028-0.02500
Operating Expenses 21.66720.00825.85518.09420.84319.82825.85216.73315.13418.3722.95124.02923.76818.27917.72815.13712.5988.00816.51215.0557.7179.51310.64210.642
Operating Income 18.54811.47715.65633.78421.79623.5927.78245.91224.78529.09730.6341.84926.2925.93528.20540.23128.91520.35929.5432.23332.89716.04624.24924.249
Operating Income Ratio 0.240.1960.1940.4390.3220.3270.2640.4280.350.3380.3180.4140.3040.3210.2960.3880.3580.3430.3290.390.3950.3060.3260.326
Total Other Income Expenses Net 9.15210.7888.3840.003-0.3990.002-0.8750.0160.003-1.065-0.234-0.1-0.097-0.1-1.3840.088-0.983-2.257-0.1360.0020.028-0.0251.3341.334
Income Before Tax 27.69922.26524.0433.78721.39723.59226.90745.92824.78828.03230.39641.74926.19325.83526.82240.3227.93218.10329.40432.23532.92516.02125.58225.582
Income Before Tax Ratio 0.3580.3810.2980.4390.3160.3270.2560.4280.350.3260.3160.4130.3020.320.2810.3890.3460.3050.3270.390.3950.3050.3440.344
Income Tax Expense 2.8533.711.792.1141.1163.543.6734.0923.4134.5865.6881.5093.164.2772.7796.3694.4173.0343.3465.3385.5673.054.4444.444
Net Income 24.99918.51621.47431.67320.28120.05223.23441.83621.37523.44624.70840.2423.03321.55824.04333.95123.51515.06826.05826.89727.35812.97121.13821.138
Net Income Ratio 0.3230.3170.2670.4110.2990.2780.2210.390.3020.2720.2570.3980.2660.2670.2520.3270.2910.2540.290.3260.3290.2470.2840.284
EPS 0.0950.070.0820.120.0770.0760.10.190.0960.110.110.180.10.10.110.170.140.0890.160.1600.0780.130.13
EPS Diluted 0.0950.070.0820.120.0770.0760.10.190.0960.110.110.180.10.10.110.170.140.0890.160.1600.0780.130.13
EBITDA 24.23720.94421.11135.6421.27523.66528.89646.66225.49625.57738.58423.14829.42521.05121.9840.44528.25821.21728.24831.833.44116.45324.83324.833
EBITDA Ratio 0.3130.3580.2620.4630.3140.3280.2750.4350.360.2970.4010.2290.340.2610.2310.390.350.3570.3150.3850.4020.3140.3340.334